The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Prevalence of Metabolic Syndrome in Patients with Psoriasis: A Population-Based Study in the United Kingdom
Open accessAbstract
Increasing epidemiological evidence suggests independent associations between psoriasis and cardiovascular and metabolic disease. Our objective was to test the hypothesis that directly-assessed psoriasis severity relates to the prevalence of metabolic syndrome and its components. Population-based, cross-sectional study using computerized medical records from The Health Improvement Network Study population included individuals aged 45-65 years with psoriasis and practice-matched controls. Psoriasis diagnosis and extent were determined using provider-based questionnaires. Metabolic syndrome was defined using National Cholesterol Education Program (NCEP) Adult Treatment Panel (ATP) III criteria. 44,715 individuals were included: 4,065 with psoriasis and 40,650 controls. 2,044 participants had mild psoriasis (≤2% body surface area (BSA)), 1,377 had moderate (3-10% BSA), and 475 had severe psoriasis (>10% BSA). Psoriasis was associated with metabolic syndrome, adjusted odds ratio (OR) 1.41 (95% CI 1.31-1.51), varying in a “dose-response” manner, from mild (adj. OR 1.22, 95% CI 1.11-1.35) to severe psoriasis (adj. OR 1.98, 95% CI 1.62-2.43). Psoriasis is associated with metabolic syndrome and the association increases with increasing disease severity. Furthermore, associations with obesity, hypertriglyceridemia and hyperglycemia increase with increasing disease severity independent of other metabolic syndrome components. These findings suggest that screening for metabolic disease should be considered for psoriasis, especially when extensive.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Grundy, S. M., Bilheimer, D. W., Chait, A., Clark, L. T., Denke, M. A., Havel, R. J., Hazzard, W. R., Hulley, S. B., Hunninghake, D. B., Kreisberg, R. A., et al. (1993) · JAMA · doi:10.1001/jama.269.23.3015 · Cited by 27,947
Expert Panel on Detection, E. (2001) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.285.19.2486 · Cited by 26,011
Ford, E. S., Giles, W. H., & Dietz, W. H. (2002) · JAMA · doi:10.1001/jama.287.3.356 · Cited by 6,698
Eckel, R. H., Alberti, K., Grundy, S. M., & Zimmet, P. Z. (2010) · The Lancet · doi:10.1016/s0140-6736(09)61794-3 · Cited by 6,295
Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001
Mokdad, A. H., Ford, E. S., Bowman, B. A., Dietz, W. H., Vinicor, F., Bales, V. S., & Marks, J. S. (2003) · JAMA · doi:10.1001/jama.289.1.76 · Cited by 5,866
Eckel, R. H., Grundy, S. M., & Zimmet, P. Z. (2005) · The Lancet · doi:10.1016/s0140-6736(05)66378-7 · Cited by 5,550
The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men
Lakka, H.-M. (2002) · JAMA · doi:10.1001/jama.288.21.2709 · Cited by 5,033
Risk of myocardial infarction in patients with psoriasis
Gelfand, J. M., Neimann, A. L., Shin, D. B., Wang, X., Margolis, D. J., & Troxel, A. B. (2006) · JAMA · doi:10.1001/jama.296.14.1735 · Cited by 1,899 · cited 3×
“Psoriasis, especially if severe, may be a risk factor for atherosclerotic CVD, beyond traditional risk factors (Gelfand et al., 2006, 2009; Mehta et al., 2010a).”
BackgroundSelf-citationCausation and Causal Inference in Epidemiology
Rothman, K. J., & Greenland, S. (2005) · American Journal of Public Health · doi:10.2105/ajph.2004.059204 · Cited by 1,259
Grundy, S. M. (2011) · Atlas of Atherosclerosis and Metabolic Syndrome · doi:10.1007/978-1-4419-5839-6_1 · Cited by 1,223
Krueger, G. G., Koo, J. Y. M., Lebwohl, M., Menter, A., Stern, R. S., & Rolstad, T. (2001) · PubMed · Cited by 969
The Metabolic Syndrome: A Global Public Health Problem and A New Definition
Zimmet, P., Magliano, D., Matsuzawa, Y., Alberti, G., & Shaw, J. (2005) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.12.295 · Cited by 877
Davidovici, B. B., Sattar, N., Jörg, P. C., Puig, L., Emery, P., Barker, J. N., van de Kerkhof, P., Ståhle, M., Nestle, F. O., Girolomoni, G., et al. (2010) · Journal of Investigative Dermatology · doi:10.1038/jid.2010.103 · Cited by 711
Mehta, N. N., Azfar, R. S., Shin, D. B., Neimann, A. L., Troxel, A. B., & Gelfand, J. M. (2010) · European Heart Journal · doi:10.1093/eurheartj/ehp567 · Cited by 706
Self-citationLewis, J. D., Schinnar, R., Bilker, W. B., Wang, X., & Strom, B. L. (2007) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.1335 · Cited by 602
Kurd, S. K., & Gelfand, J. M. (2009) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2008.09.022 · Cited by 519
Self-citationAbuabara, K., Azfar, R. S., Shin, D. B., Neimann, A. L., Troxel, A. B., & Gelfand, J. M. (2010) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2010.09941.x · Cited by 472
Self-citationThe Risk of Stroke in Patients with Psoriasis
Gelfand, J. M., Dommasch, E. D., Shin, D. B., Azfar, R. S., Kurd, S. K., Wang, X., & Troxel, A. B. (2009) · Journal of Investigative Dermatology · doi:10.1038/jid.2009.112 · Cited by 439
Self-citationWidening inequality of health in northern England, 1981-91
Phillimore, P., Beattie, A., & Townsend, P. (1994) · BMJ · doi:10.1136/bmj.308.6937.1125 · Cited by 366
Experimental Endotoxemia Induces Adipose Inflammation and Insulin Resistance in Humans
Mehta, N. N., McGillicuddy, F. C., Anderson, P. D., Hinkle, C. C., Shah, R., Pruscino, L., Tabita-Martinez, J., Sellers, K. F., Rickels, M. R., & Reilly, M. P. (2010) · Diabetes · doi:10.2337/db09-0367 · Cited by 348
Self-citationCo-morbidity and Age-related Prevalence of Psoriasis: Analysis of Health Insurance Data in Germany
Augustin, M., Reich, K., Glaeske, G., Schaefer, I., & Radtke, M. (2010) · Acta Dermato Venereologica · doi:10.2340/00015555-0770 · Cited by 337
Psoriasis and metabolic disease: epidemiology and pathophysiology
Azfar, R. S., & Gelfand, J. M. (2008) · Current Opinion in Rheumatology · doi:10.1097/bor.0b013e3283031c99 · Cited by 297
Self-citationLove, T. J., Qureshi, A. A., Karlson, E. W., Gelfand, J. M., & Choi, H. K. (2011) · Archives of Dermatology · doi:10.1001/archdermatol.2010.370 · Cited by 274
Self-citationMetabolic Syndrome and Risk of Acute Myocardial Infarction
Mente, A., Yusuf, S., Islam, S., McQueen, M. J., Tanomsup, S., Onen, C. L., Rangarajan, S., Gerstein, H. C., & Anand, S. S. (2010) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2009.12.053 · Cited by 262
Comorbidities associated with psoriasis: An experience from the Middle East
AL‐MUTAIRI, N., AL‐FARAG, S., AL‐MUTAIRI, A., & AL‐SHILTAWY, M. (2010) · The Journal of Dermatology · doi:10.1111/j.1346-8138.2009.00777.x · Cited by 177
Validity of The Health Improvement Network (THIN) for the study of psoriasis
Seminara, N. M., Abuabara, K., Shin, D. B., Langan, S., Kimmel, S. E., Margolis, D. J., Troxel, A. B., & Gelfand, J. M. (2010) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2010.10134.x · Cited by 119
Self-citationA quantitative definition of severe psoriasis for use in clinical trials
Feldman, S. R. (2004) · Journal of Dermatological Treatment · doi:10.1080/09546630310019382 · Cited by 100
BASARAB, T., Munn, S. E., & Jones, R. R. (1996) · British Journal of Dermatology · doi:10.1046/j.1365-2133.1996.d01-935.x · Cited by 76
Gene Profiling of Human Adipose Tissue During Evoked Inflammation In Vivo
Shah, R. D., Lu, Y., Hinkle, C. C., McGillicuddy, F. C., Kim, R. Y., Hannenhalli, S. S., Cappola, T. P., Heffron, S. P., Wang, X., Mehta, N. N., et al. (2009) · Diabetes · doi:10.2337/db09-0256 · Cited by 70
Self-citationMetabolic syndrome in Tunisian psoriatic patients: prevalence and determinants
Mebazaa, A., Elasmi, M., Zidi, W., Zayani, Y., Rouhou, R. C., Ounifi, S. E., Kanoun, F., Mokni, M., Osman, A. B., Feki, M., et al. (2010) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/j.1468-3083.2010.03856.x · Cited by 69
Dommasch, E. D., Shin, D. B., Troxel, A. B., Margolis, D. J., & Gelfand, J. M. (2009) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2009.09589.x · Cited by 41
Self-citationClinical Severity of Psoriasis in Last 20 Years of PUVA Study
Nijsten, T. E. C., Looman, C. W. N., & Stern, R. S. (2007) · Archives of Dermatology · doi:10.1001/archderm.143.9.1113 · Cited by 41
Cited by
Psoriasis and comorbid diseases
Takeshita, J., Grewal, S., Langan, S. M., Mehta, N. N., Ogdie, A., Van Voorhees, A. S., & Gelfand, J. M. (2017) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2016.07.064 · Cited by 1,145
Self-citationRisk Factors for the Development of Psoriasis
Kamiya, K., Kishimoto, M., Sugai, J., Komine, M., & Ohtsuki, M. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20184347 · Cited by 640
Armstrong, A. W., Harskamp, C. T., & Armstrong, E. J. (2012) · Nutrition & Diabetes · doi:10.1038/nutd.2012.26 · Cited by 514
Risankizumab versus Ustekinumab for Moderate-to-Severe Plaque Psoriasis
Papp, K. A., Blauvelt, A., Bukhalo, M., Gooderham, M., Krueger, J. G., Lacour, J.-P., Menter, A., Philipp, S., Sofen, H., Tyring, S., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1607017 · Cited by 514
Elmets, C. A., Leonardi, C. L., Davis, D. M. R., Gelfand, J. M., Lichten, J., Mehta, N. N., Armstrong, A. W., Connor, C., Cordoro, K. M., Elewski, B. E., et al. (2019) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2018.11.058 · Cited by 503
Self-citation
Metadata
- Authors
- Langan, S. M., Seminara, N. M., Shin, D. B., Troxel, A. B., Kimmel, S. E., Mehta, N. N., Margolis, D. J., & Gelfand, J. M.
- Venue
- Journal of Investigative Dermatology
- Publisher
- Elsevier BV
- Published
- 2012-03
- Volume
- 132
- Issue
- 3
- Pages
- 556-562
- ISSN
- 0022-202X (ISSN-L)
- OpenAlex
- W2105477284
- Cited by
- 525
- References
- 32
- FWCI
- 10.80
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.